The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors

por Mock, Kerstin, Preca, Bogdan-Tiberius, Brummer, Tilman, Brabletz, Simone, Stemmler, Marc P., Brabletz, Thomas
Publicado 2015

Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer

por Jolly, Mohit Kumar, Preca, Bogdan-Tiberius, Tripathi, Satyendra C., Jia, Dongya, George, Jason T., Hanash, Samir M., Brabletz, Thomas, Stemmler, Marc P., Maurer, Jochen, Levine, Herbert
Publicado 2018

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma

por Oria, Victor O., Lopatta, Paul, Schmitz, Tatjana, Preca, Bogdan‐Tiberius, Nyström, Alexander, Conrad, Catharina, Bartsch, Jörg W., Kulemann, Birte, Hoeppner, Jens, Maurer, Jochen, Bronsert, Peter, Schilling, Oliver
Publicado 2019

A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer

por Preca, Bogdan-Tiberius, Bajdak, Karolina, Mock, Kerstin, Lehmann, Waltraut, Sundararajan, Vignesh, Bronsert, Peter, Matzge-Ogi, Alexandra, Orian-Rousseau, Véronique, Brabletz, Simone, Brabletz, Thomas, Maurer, Jochen, Stemmler, Marc P.
Publicado 2017

PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer

por Amante, Romain J., Jehanno, Charly, De Silva, Duvini, Coissieux, Marie-May, Ackerknecht, Markus, Romanet, Vincent, Sethi, Atul, Hamelin, Baptiste, Preca, Bogdan-Tiberius, Piscuoglio, Salvatore, Ng, Charlotte K. Y., Mohseni, Morvarid, Bentires-Alj, Mohamed
Publicado 2023

ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer

por Strietz, Juliane, Stepputtis, Stella S., Preca, Bogdan-Tiberius, Vannier, Corinne, Kim, Mihee M., Castro, David J., Au, Qingyan, Boerries, Melanie, Busch, Hauke, Aza-Blanc, Pedro, Heynen-Genel, Susanne, Bronsert, Peter, Kuster, Bernhard, Stickeler, Elmar, Brabletz, Thomas, Oshima, Robert G., Maurer, Jochen
Publicado 2016

ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat

por Meidhof, Simone, Brabletz, Simone, Lehmann, Waltraut, Preca, Bogdan-Tiberius, Mock, Kerstin, Ruh, Manuel, Schüler, Julia, Berthold, Maria, Weber, Anika, Burk, Ulrike, Lübbert, Michael, Puhr, Martin, Culig, Zoran, Wellner, Ulrich, Keck, Tobias, Bronsert, Peter, Küsters, Simon, Hopt, Ulrich T, Stemmler, Marc P, Brabletz, Thomas
Publicado 2015

N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer

por Auf der Maur, Priska, Trefny, Marcel P., Baumann, Zora, Vulin, Milica, Correia, Ana Luisa, Diepenbruck, Maren, Kramer, Nicolas, Volkmann, Katrin, Preca, Bogdan-Tiberius, Ramos, Pedro, Leroy, Cedric, Eichlisberger, Tobias, Buczak, Katarzyna, Zilli, Federica, Okamoto, Ryoko, Rad, Roland, Jensen, Michael Rugaard, Fritsch, Christine, Zippelius, Alfred, Stadler, Michael B., Bentires-Alj, Mohamed
Publicado 2023

A high-throughput drug screen reveals means to differentiate triple-negative breast cancer

por Vulin, Milica, Jehanno, Charly, Sethi, Atul, Correia, Ana Luísa, Obradović, Milan M. S., Couto, Joana Pinto, Coissieux, Marie-May, Diepenbruck, Maren, Preca, Bogdan-Tiberius, Volkmann, Katrin, der Maur, Priska Auf, Schmidt, Alexander, Münst, Simone, Sauteur, Loïc, Kloc, Michal, Palafox, Marta, Britschgi, Adrian, Unterreiner, Vincent, Galuba, Olaf, Claerr, Isabelle, Lopez-Romero, Sandra, Galli, Giorgio G., Baeschlin, Daniel, Okamoto, Ryoko, Soysal, Savas D., Mechera, Robert, Weber, Walter P., Radimerski, Thomas, Bentires-Alj, Mohamed
Publicado 2022